The TRIUMPH-Outcomes cardiovascular and kidney trial is following adults living with obesity for several years to see whether retatrutide reduces serious heart and kidney complications, not just body weight
Role of the bloodbrain barrier in the nutrition of the central nervous system
Jastreboff and coauthors published a 48-week phase 2 trial of retatrutide in adults with obesity, the largest dataset informing the molecules metabolic effects under sustained exposure (Jastreboff et al., 2023, New England Journal of Medicine)
Nous accueillons galement la clientle prive pour tout type de projet de fabrication, transformation ou rparation Nous sommes soucieux des pratiques thiques, sociales, environnementales et respectueuses des droits de lHomme, pour ces raisons, en 2021, DESARTECH S.A
Available at (accessed 1 February 2026)
PT-141 is most commonly prescribed as a subcutaneous injection